These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1389752)

  • 1. Graft vascular disease in heart transplant patients.
    Mann J
    Br Heart J; 1992 Sep; 68(3):253-4. PubMed ID: 1389752
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular brachytherapy for treatment of cardiac allograft vasculopathy.
    Klauss V; Stempfle H; Theisen K; Kantlehner R; Poellinger B; Reichart B; Schiele TM
    J Heart Lung Transplant; 2001 Jul; 20(7):792-4. PubMed ID: 11448814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft vasculopathy among recipients of heart transplantation during the first 12 years of life. The Pediatric Heart Transplant Group.
    Bailey LL; Zuppan CW; Chinnock RE; Johnston JK; Razzouk AJ; Gundry SR
    Transplant Proc; 1995 Jun; 27(3):1921-5. PubMed ID: 7792838
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute rejection and cytomegalovirus infection: correlation with cardiac allograft vasculopathy.
    Mangiavacchi M; Frigerio M; Gronda E; Danzi GB; Bonacina E; Masciocco G; Olivia F; De Vita C; Pellegrini A
    Transplant Proc; 1995 Jun; 27(3):1960-2. PubMed ID: 7792851
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of PTCA in the management of focal critical lesions in transplant coronary artery disease.
    von Scheidt W; Uberfuhr P; Reichart B; Steinbeck G
    Transplant Proc; 1995 Jun; 27(3):1936-8. PubMed ID: 7792842
    [No Abstract]   [Full Text] [Related]  

  • 6. Directional coronary atherectomy in heart transplant recipients.
    Jain SP; Ventura HO; Ramee SR; Collins TJ; Isner JM; White CJ
    J Heart Lung Transplant; 1993; 12(5):819-23. PubMed ID: 8241222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation factors as predictors of transplant-associated coronary artery disease.
    Labarrere CA
    J Heart Lung Transplant; 2000 Jul; 19(7):623-33. PubMed ID: 10930810
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathology of graft coronary disease.
    Billingham ME
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S38-44. PubMed ID: 1622997
    [No Abstract]   [Full Text] [Related]  

  • 9. [Coronary pathology after heart transplantation].
    Desruennes M; Drobinski G; Chomette G; Autran B; Pavie A; Léger P; Gandjbakhch I; Jault F; Grosgogeat Y; Cabrol C
    Presse Med; 1992 Apr; 21(14):670-5. PubMed ID: 1317962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dobutamine stress echocardiography for detection of transplant coronary vasculopathy: comparison with angiography and intracoronary ultrasound.
    Spes CH; Mudra H; Schnaack SD; Klauss V; Rieber J; Reichle F; Krüger TM; Uberfuhr P; Angermann CE; Theisen K
    Transplant Proc; 1995 Jun; 27(3):1973-4. PubMed ID: 7792855
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research progress of diagnosis in heart transplant associated coronary artery disease].
    Liu XH; Yang TH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):82-4. PubMed ID: 19099937
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary occlusive disease and late graft failure after cardiac transplantation.
    Mullins PA; Cary NR; Sharples L; Scott J; Aravot D; Large SR; Wallwork J; Schofield PM
    Br Heart J; 1992 Sep; 68(3):260-5. PubMed ID: 1389755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does donor and recipient sex influence the development of cardiac allograft vasculopathy?
    Mehra MR; Ventura HO; Escobar A; Cassidy CA; Smart FW; Stapleton DD
    Transplant Proc; 1995 Jun; 27(3):1926-9. PubMed ID: 7792839
    [No Abstract]   [Full Text] [Related]  

  • 14. Qualitative and quantitative assessment of cardiac allograft vasculopathy by intravascular ultrasound.
    Klauss V; Rieber J; Uberfuhr P; Theisen K; Mudra H
    Transplant Proc; 1995 Jun; 27(3):1975-6. PubMed ID: 7792856
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of HLA compatibility on the incidence of cardiac allograft vasculopathy after heart transplantation.
    Stempfle HU; Mudra H; Strom C; Angermann CE; Klauss V; Rieber J; Scholz S; Spes C; Uberfuhr P; Theisen K
    Transplant Proc; 1995 Jun; 27(3):1977-8. PubMed ID: 7792857
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac graft vasculopathy: aetiologic factors and therapeutic approaches.
    Conraads V; Lahaye I; Rademakers F; Heuten H; Rodrigus I; Vrints C; Moulijn A
    Acta Cardiol; 1998; 53(1):37-43. PubMed ID: 9638969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac transplant vasculopathy treated by percutaneous coronary intervention.
    Perrotta S; Lentini S; Muré P; Rinaldi M; D'Armini AM; Viganó M
    Minerva Chir; 2008 Oct; 63(5):321-7. PubMed ID: 18923342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis.
    Billingham ME
    Transplant Proc; 1995 Jun; 27(3):2013-6. PubMed ID: 7792870
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe left main stem stenosis in a cardiac transplant recipient: successful treatment by coronary stenting.
    Price DJ; Hall JA; Forty J
    J Invasive Cardiol; 2000 Jul; 12(7):369-72. PubMed ID: 10904445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance cardiac catheterisation in heart transplant recipients.
    Kim CB; Yeung AC
    Heart; 1997 Aug; 78(2):103-4. PubMed ID: 9326977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.